ARMATA PHARMACEUTICALS, INC. Prepaid Expense and Other Assets, Current
ARMATA PHARMACEUTICALS, INC. (ARMP) had Prepaid Expense and Other Assets, Current of $673.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $673.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.15M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.51M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.42M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $673.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.15M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.51M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.42M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.02M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.24M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.27M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $3.03M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $3.26M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.14M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $2.27M 10-K · filed 2025-03-21 | |
| 2023-03-31 | $12.23M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.66M 10-K · filed 2024-03-21 | $10.26M 10-K · filed 2023-03-16 |
| 2022-09-30 | $6.00M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $2.44M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.05M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.72M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $851.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.00M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $459.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $636.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $804.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $898.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $567.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $622.00K 10-K · filed 2021-03-18 | |
| 2019-09-30 | $652.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.01M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $407.00K 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $697.00K 10-K · filed 2020-03-19 | $251.00K 10-K · filed 2019-03-25 |
| 2018-09-30 | $615.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $322.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $537.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $253.00K 10-K · filed 2019-03-25 | |
| 2017-09-30 | $264.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $282.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $343.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $602.00K 10-K · filed 2018-03-14 | $619.00K 10-K · filed 2017-03-27 |
| 2016-09-30 | $570.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $576.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $566.00K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $521.00K 10-K · filed 2017-03-27 | |
| 2015-09-30 | $785.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $512.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $413.00K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $339.00K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $448.00K 10-Q/A · filed 2015-04-15 | $279.00K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $526.00K 10-Q/A · filed 2015-04-15 | $297.00K 10-Q · filed 2014-09-12 |
| 2014-03-31 | $345.00K 10-Q/A · filed 2015-04-15 | $280.00K 10-Q · filed 2014-05-20 |
| 2013-12-31 | $297.00K 10-Q/A · filed 2015-04-15 | $171.00K 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |